Inventor · disambiguated record
Robert Than Hendricks
Also filed as: HENDRICKS ROBERT T · HENDRICKS ROBERT THAN
24 granted patents·7 pending applications·558 citations·filing 1978–2022
96Inventor score
Files withALIOS BIOPHARMA INC5JANSSEN BIOPHARMA INC5ROCHE PALO ALTO LLC5HENDRICKS ROBERT THAN4SYNTEX INC4
Top patents by PatentIndex Score
31 records- 0197US7902197B2Pyrrolopyrazine kinase inhibitorsROCHE PALO ALTO LLC·Filed 2009·Granted Mar 8, 2011·106 cites·23 claims
- 0295US7939531B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted May 10, 2011·61 cites·32 claims
- 0395US7932254B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted Apr 26, 2011·60 cites·47 claims
- 0493US9328119B2AZA-pyridone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2014·Granted May 3, 2016·15 cites·42 claims
- 0592US6143744ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1999·Granted Nov 7, 2000·55 cites·46 claims
- 0691US5998412ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1998·Granted Dec 7, 1999·52 cites·15 claims
- 0790US10702523B2AZA-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Jul 7, 2020·3 cites·32 claims
- 0890US6376506B1Sulfamide-metalloprotease inhibitorsSYNTEX LLC·Filed 1999·Granted Apr 23, 2002·47 cites·5 claims
- 0989US7674810B21,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymeraseROCHE PALO ALTO LLC·Filed 2006·Granted Mar 9, 2010·8 cites·15 claims
- 1088US10183945B2Method of preparing AZA-pyridone compoundsALIOS BIOPHARMA INC·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 1188US5932595AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1996·Granted Aug 3, 1999·88 cites·60 claims
- 1287US10208045B2Aza-pyridone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2016·Granted Feb 19, 2019·7 cites·39 claims
- 1387US7479489B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2005·Granted Jan 20, 2009·7 cites·41 claims
- 1486US10251882B2Aza-pyridone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2016·Granted Apr 9, 2019·4 cites·33 claims
- 1583US6130220ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1999·Granted Oct 10, 2000·30 cites·44 claims
- 1679US10364226B2Pyridazinone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2014·Granted Jul 30, 2019·3 cites·36 claims
- 1778US10980805B2Aza-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 20, 2021·0 cites·9 claims
- 1877US8008298B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted Aug 30, 2011·3 cites·42 claims
- 1973US2021186969A1Aza-pyridone compounds and uses thereofJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2072US8119636B2Pyrrolopyrazine kinase inhibitorsDUBOIS DAISY JOE·Filed 2009·Granted Feb 21, 2012·3 cites·25 claims
- 2165US2023002409A1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2264US11312727B1Macrocyclic flu endonuclease inhibitorsJANSSEN BIOPHARMA INC·Filed 2019·Granted Apr 26, 2022·0 cites·16 claims
- 2357US2023391756A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2452US2014155376A1Pyrrolopyrazine kinase inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2545US2004121969A1Antiviral nucleoside derivativesROCHE PALO ALTO LLC·Filed 2003·Application pending·0 cites
- 2642US2011288067A1Pyrrolopyrazine Kinase InhibitorsHENDRICKS ROBERT THAN·Filed 2011·Application pending·0 cites
- 2737US2011070190A1Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2010·Application pending·0 cites
- 2835US8329699B2Pyrrolopyrazine kinase inhibitorsHENDRICKS ROBERT THAN·Filed 2011·Granted Dec 11, 2012·0 cites·16 claims
- 2934US8518945B2Pyrrolopyrazine kinase inhibitorsHENDRICKS ROBERT THAN·Filed 2011·Granted Aug 27, 2013·0 cites·16 claims
- 3034US8481541B2Pyrrolopyrazine kinase inhibitorsHENDRICKS ROBERT THAN·Filed 2011·Granted Jul 9, 2013·0 cites·16 claims
- 3124US4171586APurse seine hairpin retainerHENDRICKS ROBERT T·Filed 1978·Granted Oct 23, 1979·1 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →